Introduction 52
Among the individuals infected by the human immunodeficiency virus type 1 (HIV-1), a rare group 53 called HIV controllers (HIC) suppress viral replication in absence of antiretroviral therapy, 54 maintaining RNA viral loads (VL) undetectable (< 50-80 copies/mL; elite controllers, EC) or at low 55 levels (50-2,000 copies/mL; viremic controllers, VC). Natural control of HIV-1 replication is 56 probably a multifactorial feature that involves different combinations of host and/or viral factors (1). 57
Several host restriction factors (RF), which constitute components of the innate immune response, 58
have been shown to limit HIV-1 replication in vitro (2). Importantly, a few RF are elevated in 59 peripheral blood mononuclear cells (PBMC) of HIC compared to antiretroviral (ART)-suppressed 60 and/or HIV-uninfected individuals (3-10), suggesting a role of host cell RF in the natural control of 61 HIV-1 replication in vivo. 62
The cyclin-dependent kinase (CDK) inhibitor p21 is a multifunctional modulator of a broad range of 63 biological processes like cell proliferation, that also indirectly limit the HIV-1 replication by blocking 64 the biosynthesis of dNTPs required to viral reverse transcription and by inhibiting the CDK9 activity 65 required by HIV-1 for viral mRNA transcription (6). The protein p21 has been shown to inhibit HIV-66 1 replication in vitro in various cellular systems (6,11-15) and is further expressed at high levels ex 67 vivo in CD4 + T cells from HICs (4,6,9,16). Another study revealed that p21 mRNA levels correlated 68 with CD4 + T cell activation in EC, but not in other HIV-infected groups, suggesting that the 69 inducibility of this RF to immune activation is a singular characteristic of EC and may contribute to 70 this special phenotype (3). 71
The monocyte chemotactic protein-induced protein 1 (MCPIP1) is a protein with a critical role in the 72 regulation of the inflammatory response and immune homeostasis that also block HIV-1 replication 73 by promoting the viral mRNA degradation through its RNase activity (17,18 
Study Subjects 89
We analyzed a cohort of 21 HIC subjects followed-up at the Instituto Nacional de Infectologia 90
Evandro Chagas (INI) in Rio de Janeiro, Brazil. All HIC maintained RNA VL of < 2,000 copies/ml 91 without antiretroviral therapy for at least five years and were subdivided in two sub-groups: EC (n = 92 13) when most (≥ 70%) plasma VL determinations were below the detection limit (< 40-80 copies/ml 93 depending on the VL method used along patient follow-up), and VC (n = 8) when most (≥ 70%) VL 94 determinations were between 41-2,000 copies/ml. Virological and immunological characteristics of 95 these subjects were described in detail in previous studies (20, 21 
CD4 + T cell and monocyte activation analyses 118
We used data of CD4 + T cell and monocyte activation obtained in a previous study conducted by our 119 group including these patients (21), in which plasma levels of soluble CD14 (sCD14) were 120 determined by ELISA-sCD14 Quantikine assay (R&D Systems Minneapolis, MN) according to the 121 manufacturer's protocol and surface expression of comnined HLA-DR and CD38 on CD4 + T cells 122 was analyzed by flow cytometry. 123
Data analyses 124
The comparisons of mean log-fold changes in mRNA abundance were performed by either t-tests or 125 one-way ANOVA nonparametric permutation tests (B = 1,000 permutations), followed by pair-wise 126 comparisons with Holm-Bonferroni adjustment (23), for two or more groups respectively. Spearman 127 coefficient was used for correlation analyses. A first-order log-Normal multiple regression analysis 128 was fitted to model p21 gene expression as a function of MCPIP1 gene expression, CD4 + T cell 129 activation (HLA-DR + CD38 + ), and HIC groups (EC and VC). The threshold for statistical 130 significance was set to P < 0.05. Data were analyzed with R software (version 3.5.2) (24). were females and all individuals displayed CD4 + T cells counts above 500 cells/μl (Table 1) .
Analyses of host RF expression revealed a significant upregulation of p21 and MCPIP1 in HIC 137 ( Figure 1 ). The p21 mRNA was up-regulated in PBMCs from HIC compared to cells from both 138 ART-suppressed (1.63-fold increase; P = 0.003) and HIV-negative (1.55-fold increase; P = 0.003) 139 subjects ( Figure 1A ). Significant overexpression of the MCPIP1 mRNA in PBMC from HIC 140 compared to ART-suppressed (1.68-fold increase; P = 0.003) and HIV-negative (1.37-fold increase; 141 P = 0.02) individuals was also observed ( Figure 1B) . Expression of p21 mRNA was significantly (P 142 < 0.025) elevated in PBMCs from both EC and VC compared to control groups ( Figure 1C ). 143
Expression of MCPIP1 mRNA was also elevated in EC and VC subsets compared with ART-144 suppressed and HIV-negative groups, although the difference with HIV-negative group did not reach 145 statistical significance ( Figure 1D ). With respect to EC and VC, p21 and MCPIP1 mRNA expression 146 levels were equally significant. Of note, the expression of other antiretroviral RF shows no statistical 147 differences between the HIC and control groups, with exception of IFITM1 that was significantly 148 elevated (1.15-fold increase; P = 0.03) in HIC in comparison to the HIV-negative group 149 (Supplementary Figure S1) . Moreover, we found a significant positive correlation between p21 and 150 MCPIP1 mRNA expression (r ≥ 0.57; P ≤ 0.014) independently of the VL, treatment condition and 151 HIV status (Figure 2 ). With respect to other RF, only a modest, but significant, negative correlation 152 between p21/MCPIP1with APOBEC3G mRNA in HIC was observed (Supplementary Figure S2) . 153
To explore the potential relationship of p21 or MCPIP1 expression with immune activation and 154 inflammation, we measured the frequency of CD4 + HLA-DR + CD38 + T cells and plasma sCD14 levels 155 (monocyte activation) in our cohort. Frequencies of activated CD4 + T cell populations in VC and 156 ART-suppressed subjects were similar; nevertheless, higher than in EC (P < 0.0001) and HIV-157 negative (P = 0.0002) individuals ( Figure 3A) . The median concentration of sCD14 in plasma was 158 not significantly different across the groups ( Figure 3B ). The mRNA levels of p21 were positively 159 associated with activated CD4 + T cells levels in HIC (r = 0.53; P = 0.016) and EC (r = 0.68; P = 160 0.017) ( Figure 3C ). No significant correlations between mRNA levels of MCPIP1 and CD4 + T cell 161 activation were observed for HIC or EC subsets ( Figure 3D ). Levels of sCD14 were positively 162 correlated with both p21 (r = 0.74; P = 0.005) and MCPIP1 (r = 0.58; P = 0.04) mRNA levels only in 163 the EC subset ( Figure 3E Figure S4B) . Overall, the model was 172 highly significant (P = 0.003) and could explain as much as 70% (R 2 = 0.492) of p21 expression. 173
Discussion 174
In this study, we observed that p21 and MCPIP1 mRNA expression were significantly increased in 175 PBMC of HIC compared to cells of HIV-negative and -positive/ART-suppressed individuals. The 176 elevated expression of p21 in PBMC of HIC had already been previously described (3,4,6,9,16). 177
Originally, this is the first study to show overexpression of MCPIP1 alongside with p21 in these 178 individuals. The mRNA levels of p21 and MCPIP1 were positively correlated in HIC as well as in 179
HIV-positive and -negative individuals. This supports a coordinated expression of these cellular 180 genes in different settings, consistent with what has been shown for a renal carcinoma cell line (19). 181
Other host RF, such as SAMHD1, SLFN11, and Mx1, previously found to be overexpressed in CD4 + 182
T cells from HIC (3,7,8), were not up-regulated in PBMC from our HIC cohort, which may reflect 183 differences in the cellular populations analyzed (8). A recent study (10), however, described 184 upregulation of tetherin and SLFN11 in PBMC from HIC, supporting that the contrasting findings 185 across studies might also reflect inter-cohort diversity (1). Indeed, we detected in our HIC cohort a 186 few individuals that displayed mRNA levels of SAMHD1 and/or SLFN11 well above the normal 187 range (Supplementary Figure S1) The enhanced expression of a few select host RF, including p21, was strongly associated with 223 reduced CD4 + T cell-associated HIV RNA during ART, indicating that this host RF may contribute 224 to the control of viral expression and ongoing replication during ART (54). Another study 225
demonstrates that atorvastatin, a lipid-lowering medication, exert a broad spectrum of anti-226 inflammatory functions and further reduced HIV infection in both rested and activated CD4 + T cells 227 in vitro via p21 upregulation (14). Interestingly, atorvastatin was found to up-regulates p21 through a 228 p53 independent pathway, which is consistent with a potential role of MCPIP1 in that antiviral 229 mechanism. These observations suggest that pharmacological manipulation of p21 and MCPIP1 may 230 open novel therapeutic perspectives to prevent HIV-1 replication and to attenuate HIV-associated 231 inflammation and immune activation during ART. 232
An important limitation of our study is the impossibility of assigning which cell(s) population(s) has 233 increased expression of p21 and MCPIP1 in HIC. The expression profile of many RF and ISGs may 234 be different between CD4 + T cells and monocytes (8), suggesting that the individualization of these 235 cell types might better decipher the mechanisms of RF regulation in the setting of natural control of 236 HIV-1 infection. Another potential limitation is that only RF mRNA levels were analyzed. Previous 237 studies showed that p21 mRNA levels mirror p21 protein levels in CD4 + T cells from HIC (6) and 238 that MCPIP1 mRNA levels reflect MCPIP1 protein levels in HCV-infected hepatoma cells (55). 239
Although these evidences indicate a close match between transcripts and protein expression levels, 240 measuring the levels/activity of p21 and MCPIP1 proteins in cells from HIC should also help to 241 elucidate the relevance of these RF for HIV control. 
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